Dupont Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-25,664
| Closed | -$1.16M | – | 1356 |
|
|
2019
Q4 | $1.16M | Hold |
25,664
| – | – | 0.03% | 528 |
|
|
2019
Q3 | $977K | Buy |
+25,664
| New | +$977K | 0.02% | 532 |
|
|
2017
Q4 | – | Sell |
-15,090
| Closed | -$567K | – | 981 |
|
|
2017
Q3 | $567K | Buy |
15,090
+1,821
| +14% | +$68.4K | 0.01% | 647 |
|
|
2017
Q2 | $633K | Sell |
13,269
-5,192
| -28% | -$248K | 0.01% | 628 |
|
|
2017
Q1 | $842K | Sell |
18,461
-5,087
| -22% | -$232K | 0.02% | 558 |
|
|
2016
Q4 | $761K | Buy |
23,548
+17,791
| +309% | +$575K | 0.02% | 553 |
|
|
2016
Q3 | $197K | Hold |
5,757
| – | – | ﹤0.01% | 641 |
|
|
2016
Q2 | $194K | Hold |
5,757
| – | – | ﹤0.01% | 648 |
|
|
2016
Q1 | $305K | Sell |
5,757
-7,232
| -56% | -$383K | 0.01% | 593 |
|
|
2015
Q4 | $997K | Buy |
+12,989
| New | +$997K | 0.02% | 472 |
|